SeaSpine Holdings (SPNE) Prices 6.8M Share Common Offering at $12.50/Sh

Go back to SeaSpine Holdings (SPNE) Prices 6.8M Share Common Offering at $12.50/Sh

After-Hours Stock Movers 01/07: (VTVT) (ATEN) (COLL) Higher; (EXFO) (LTHM) (RADA) Lower (more...)

January 7, 2020 6:00 PM EST

Today's After-Hours Stock Movers:

EXFO, Inc. (NASDAQ: EXFO) 18.4% LOWER; reported Q1 EPS of $0.00, $0.04 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $73.6 million versus the consensus estimate of $72.96 million. EXFO, Inc. sees Q2 2020 EPS of ($0.09)-($0.05), versus the consensus of $0.07. EXFO, Inc. sees Q2 2020 revenue of $66-71 million, versus the consensus of $75.25 million.

Livent Corporation (NYSE: LTHM) 16.6% LOWER; has revised its fourth quarter and full-year 2019 financial guidance. The company now expects... More

SeaSpine Holdings (SPNE) Commences Public Offering of Common Stock

January 7, 2020 4:03 PM EST

SeaSpine Holdings Corporation (NASDAQ: SPNE) (SeaSpine or the Company), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today that it has commenced an underwritten public offering of shares of its common stock. All of the shares... More

SeaSpine Holdings (SPNE) reports prelim. Q4 results, expects full-year 2020 revenue to be in the range of $177 to $181 million

January 7, 2020 4:01 PM EST

SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today preliminary financial results for the fourth quarter and full-year 2019, with U.S Spinal Implants revenues expected to reflect growth within the 20% to 21% range.

We are pleased by our overall strong revenue performance in the fourth quarter and, in particular, the growth in excess of 20% in the U.S. Spinal Implants portfolio, said Keith Valentine, President and Chief Executive Officer. Based on the... More